Tuesday, 19 November 2019

Vaccines News

  • China's Hualan Bio gets WHO nod for influenza vaccine

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2015

    Singapore: China based Hualan Bio has recieved world health organization (WHO) pre-qualification approval for influenza vaccine and is taken into UN purchase plan. Flu is one of the most s...Read more

  • Teikoku Pharma gets USFDA nod for non-alcohol docetaxel injection

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2016

    Singapore: Japan's Teikoku Pharma has recieved USFDA approval for Docetaxel injection, a non-alcohol formula for the treatment of breast cancer, non-small cell lung cancer, prostate cancer,...Read more

  • German firm proceeds on ebola vaccine trial

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2015

    Singapore: Germany based complex biologics development and manufacturing specialist, ProBioGen, has proceeded on the clinical trial of its investigational vaccine against Ebola virus diseas...Read more

  • Merck's Ebola vaccine found promising in clinical trials

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2015

    Singapore: In a recent interim study published in the Lancet medical journal, Merck's Ebola vaccine was found to be "highly effective," in clinical trials. The vaccine was tested on more th...Read more

  • Teva recalls Adrucil injection for potential foriegn particle presence

    Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 28 Jul, 2015

    Singapore: Teva Parenteral Medicines has recalled six lots of Adrucil (fluorouracil injection) due to the potential presence of particulate matter identified as aggregate of silicone rubber...Read more

  • Drug resistance keeps malaria threat alive in India

    Vaccines |  Analysis | By Rahul Koul Koul | 0 Comment | 02 Jul, 2012

    The current anti-malarial market in India is approximately $80 million (Rs 450 crore) with an annual growth rate of 17 percent, says a report by ORG IMS in Nov 2011. According to statistics...Read more

  • New vaccine against Hepatatis B developed by Cuba

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 17 Aug, 2015

    Singapore: Researchers from Cuba have developed a new vaccine for treatment of chronic hepatitis B. The vaccine HeberNasvac, developed in cooperation French company Abivax, is currently und...Read more

  • Malaria vaccine, Mosquirix, gets European nod

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2015

    Singapore: GlaxoSmithKline has received a positive opinion for its Malaria vaccine candidate from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...Read more

  • Novavax's Ebola vaccine shows promise in human trial

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2015

    Singapore: US-based Novavax recently announced that its experimental candidate vaccine for Ebola showed promise in early stage human clinical trial. The vaccine induced a substantial immune...Read more

  • No more needles, no more pain!

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2015

    Singapore: Vaccination will no longer be a painful process as researchers from Japan's Osaka University have developed a new technique that can deliver vaccines without needles. The new met...Read more

  • Shanghai BravoBio wins BioSpectrum award for role in China vaccine industry

    Vaccines |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    Chinese vaccine development companies are raising the bar to meet international standards. However, access to foreign markets remains a challenge. Shanghai BravoBio, which has a strong and ...Read more

  • WHO and World Food Program join forces to reach zero Ebola cases

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2015

    Singapore: WHO and United Nations World Food Program (WFP) have come together to build logistics strength for Ebola-affected countries of Guinea, Liberia and Sierra Leone to help get the cu...Read more

  • FDA nod for Sanofi quadrivalent flu vaccine

    Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2013

    Singapore: The US FDA has approved Sanofi Pasteur supplemental biologics license application (sBLA) for its four-strain influenza vaccine, Fluzone Quadrivalent, which is the newest addition...Read more

  • Vaccine for AIDS in ten years: Bill Gates

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2015

    Singapore: With no cure or vaccine available for AIDS, that is spreading across the globe like a wide epidemic, billionaire philanthropist Mr Bill Gates, who spends millions of dollars on A...Read more

  • AIDS 2014: Slash in fund jolts HIV research

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2014

    Singapore: Investment in HIV prevention research has declined posing a challenge to the pipeline of HIV prevention products in various stages of development and implementation of an effecti...Read more

  • Novartis completes divestiture of influenza vaccines business

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 18 Aug, 2015

    Singapore: Novartis has announced that it has completed the divestiture of its influenza vaccine unit to CSL Limited. This marks the end of a series of transactions previously announced and...Read more

  • J&J's HIV vaccine to begin human trials

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2015

    Singapore: Bringing new hope to millions of people worldwide, the experimental HIV vaccine developed by Johnson & Johnson has shown promise in early clinical trials. As per reports the ...Read more

  • Agilent, A*Star, French univ sign biologics MoU

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 27 May, 2013

    Singapore: Agilent Technologies, Glyco-MEV laboratory at the University of Rouen, France, and Bioprocessing Technology Institute (BTI) at the Agency for Science, Technology and Research (A*...Read more